HPSE and Hyperglycemia: Hyperglycemia following pancreatic β-cell injury through STZ treatment suppresses the expression of the transcription factor PPARγ, resulting in the cancellation of the inhibition of heparanase expression by PPARγ and the promotion of HS degradation on pancreatic islets by heparanase [17].